These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Adult height in advanced puberty with or without gonadotropin hormone releasing hormone analog treatment. Couto-Silva AC; Adan L; Trivin C; Brauner R J Pediatr Endocrinol Metab; 2002 Mar; 15(3):297-305. PubMed ID: 11924932 [TBL] [Abstract][Full Text] [Related]
7. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience. Kohn B; Julius JR; Blethen SL Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254 [TBL] [Abstract][Full Text] [Related]
9. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height. Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638 [TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153 [TBL] [Abstract][Full Text] [Related]
11. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857 [TBL] [Abstract][Full Text] [Related]
12. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone. Cara JF; Kreiter ML; Rosenfield RL J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661 [TBL] [Abstract][Full Text] [Related]
13. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty]. Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866 [TBL] [Abstract][Full Text] [Related]
14. Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists. Wacharasindhu S; Srivuthana S; Aroonparkmongkol S; Supornsilchai V; Hiranrat P; Yodvisitsak V J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S170-3. PubMed ID: 12929985 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. Quintos JB; Vogiatzi MG; Harbison MD; New MI J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576 [TBL] [Abstract][Full Text] [Related]
16. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone. Mul D; Oostdijk W; Waelkens JJ; Drop SL Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912 [TBL] [Abstract][Full Text] [Related]
17. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study. Saggese G; Federico G; Barsanti S; Fiore L J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181 [TBL] [Abstract][Full Text] [Related]
18. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth]. Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553 [TBL] [Abstract][Full Text] [Related]
19. Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation. Adan L; Sainte-Rose C; Souberbielle JC; Zucker JM; Kalifa C; Brauner R Med Pediatr Oncol; 2000 Jan; 34(1):14-9. PubMed ID: 10611579 [TBL] [Abstract][Full Text] [Related]
20. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty. van Gool SA; Kamp GA; Visser-van Balen H; Mul D; Waelkens JJ; Jansen M; Verhoeven-Wind L; Delemarre-van de Waal HA; de Muinck Keizer-Schrama SM; Leusink G; Roos JC; Wit JM J Clin Endocrinol Metab; 2007 Apr; 92(4):1402-8. PubMed ID: 17284626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]